EX-99.1 3 shire8k062503ex.txt PRESS RELEASE Shire Pharmaceuticals Group plc Hampshire International Business Park, Chineham, Basingstoke RG24 8EP UK Tel +44 1256 894000 Fax +44 1256 894708 http://www.shire.com Shire 25 June 2003 Shire Pharmaceuticals Group plc (the 'Company') Share Repurchase The Company announces that on 24 June 2003 it purchased for cancellation 440,000 of its ordinary shares of (pound)0.05 each at a price of 402.49p per share and 60,000 of its ordinary shares of (pound)0.05 each at a price of US$6.73 per share. T May Company Secretary For further information please contact: Gordon Ngan - Investor Relations +44 1256 894 160 Notes to editors Shire Pharmaceuticals Group plc Shire Pharmaceuticals Group plc (Shire) is a rapidly growing international emerging pharmaceutical company with a strategic focus on four therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI), oncology, and anti-infectives. Shire also has three platform technologies: advanced drug delivery, lead optimization for small molecules and Biologics. Shire's core strategy is based on research and development combined with in-licensing and a focus on eight key pharmaceutical markets. For further information on Shire, please visit the Company's website: www.shire.com